Pedro Crisanto

Pedro Crisanto

R&D Chief Operating Officer

Pedro Crisanto is the R&D Chief Operating Officer at Servier Pharmaceuticals. In this role, Pedro leads the R&D managers based in the U.S., promotes the implementation of new ways of working and leverages local opportunities.

With nearly 20 years of experience, Pedro is a committed leader in the pharmaceutical industry across multiple functions and countries. He began his career at Servier in his home country of Portugal where he supported the launch of the Portuguese Clinical Operations Department. Following this, Pedro held a global role as Deputy Worldwide Clinical Operations Manager at Servier’s headquarters in Paris. During his time in Paris, Pedro supported global initiatives across different structures, countries and cultures. Prior to joining the U.S.-based office, Pedro spent seven years working as the Director of the International Centre for Therapeutic Research Australia, New Zealand, Southeast Asia, and India generating successful outcomes in clinical research, company awareness, and external innovation.

As member of the U.S. R&D leadership council, Pedro is an active voice for R&D promoting the alignment of local initiatives with the global strategy and contributing to developing a high-performance and engaged atmosphere.

Pedro graduated from the Faculty of Pharmacy of the University of Lisbon and has a Bachelor of Advanced Studies in Pharmaceutical Medicine from the European Centre of Pharmaceutical Medicine, Basel University in Switzerland.

To learn more about Pedro connect with him on LinkedIn.

More from Servier

About Us

Servier Pharmaceuticals is a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.

Learn More


Servier Pharmaceuticals is an independent, privately held United States company launched by Servier Group, a unique global organization, and is governed by a non-profit foundation.

Learn More


Servier has a 65-year history of helping provide innovative medicines to patients globally. In the United States, Servier intends to uphold and build upon that history. 

Learn More